Skip to content

Mannkind MNKD Operating lease right-of-use asset amortization

Operating lease right-of-use asset amortization at other companies

Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
Omada Health, Inc. Common Stock logo
Omada Health, Inc. Common StockOMDA
Viking Therapeutics logo
Viking TherapeuticsVKTX
Merit Medical Systems logo
Merit Medical SystemsMMSI
AdaptHealth logo
AdaptHealthAHCO
Savara logo
SavaraSVRA

Other financials

Income statement

See full
Revenue$90.2M+15.1%
Gross profit$82.7M+10.8%
Operating income-$1.7M-107%
Net income-$16.6M-226%
EPS (diluted)-$0.05-225%

Balance sheet

See full
Cash & equivalents$52.8M+11.7%
Total debt$12.2M-9.4%
Total equity-$59.2M-1.0%
Total assets$744.4M+81.5%

Cash flow

See full
Operating cash flow-$5.4M+15.9%
CapEx$1.9M+470%
Free cash flow-$7.2M-8.0%

Valuation

See full
Market cap$1.19B+3.5%
Enterprise value$1.15B+3.0%
P/E228.5×
P/S3.3×-0.6×

Profitability

See full
Gross margin91.5%-2.6pp
Operating margin23.3%+3.1pp
Net margin9.3%
FCF margin13.8%

Returns & leverage

See full
Return on equity-8.8%
Debt / equity-0.2×
Current ratio1.9×-0.5×

Where this comes from

Reported directly by Mannkind in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: Mannkind’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mannkind's operating lease right-of-use asset amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mannkind's operating lease right-of-use asset amortization?
Mannkind (MNKD) reported operating lease right-of-use asset amortization of $532K in Q1 2026.
How has Mannkind's operating lease right-of-use asset amortization changed year-over-year?
Mannkind's operating lease right-of-use asset amortization decreased by 2.2% year-over-year, from $544K to $532K.
What is the long-term trend for Mannkind's operating lease right-of-use asset amortization?
Over 2 years (2022 to 2024), Mannkind's operating lease right-of-use asset amortization has grown at a -25.3% compound annual growth rate (CAGR), from $2.99M to $1.67M.